To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.

10/4/2024, 8:07 PM

Congressional Summary of HR 7347

This bill requires the Department of Veterans Affairs (VA), when a psychedelic drug is approved or licensed by the Food and Drug Administration, to report on the VA's decision whether to include the drug in its formulary and the justification for such decision.

Current Status of Bill HR 7347

Bill HR 7347 is currently in the status of Bill Introduced since February 14, 2024. Bill HR 7347 was introduced during Congress 118 and was introduced to the House on February 14, 2024.  Bill HR 7347's most recent activity was Placed on the Union Calendar, Calendar No. 544. as of September 6, 2024

Bipartisan Support of Bill HR 7347

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7347

Primary Policy Focus

Armed Forces and National Security

Potential Impact Areas

Alternative treatmentsCongressional oversightDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugs

Alternate Title(s) of Bill HR 7347

To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
Start holding our government accountable!

Comments